Renal cell carcinoma.

Renal cell carcinoma. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Renal cell carcinoma. Abstract Text:

Brian I Rini,Steven C Campbell,W Kimryn Rathmell,Brian I Rini,Steven C Campbell,W Kimryn Rathmell,

PURPOSE OF REVIEW: In this review we will highlight the recent novel contributions to the treatment of renal cell carcinoma in the fields of anti-angiogenesis, immunotherapeutics, and surgical management. In addition, this review will update recent advances in diagnostic and imaging modalities for renal cell carcinoma and dietary and environmental relationships to the epidemiology of this growing disease. RECENT FINDINGS: Advancements in the use of innovative treatment strategies for the management of localized renal cell carcinoma and the introduction of new targeted therapeutics with benefit in the metastatic setting has produced a major impact on the treatment of this disease. SUMMARY: The management of metastatic renal cell carcinoma has undergone a revolution in the past year with groundbreaking treatment strategies encompassing a broad range of therapeutic modalities. At the other end of the spectrum, emerging data is beginning to change our perspective about the management of small, localized renal tumors that are being discovered with increasing frequency. This review will update recent findings supporting diet and tobacco exposure as etiologic factors in the development of renal cell carcinoma, the molecular concepts that underlie the disease and the targeted therapeutics designed to inhibit specific kinase activities, and emerging use of minimally invasive therapies for localized disease.

Renal cell carcinoma. Publishing Authors By Initials

BI Rini,SC Campbell,WK Rathmell,BI Rini,SC Campbell,WK Rathmell,

For similar surgical procedures, operative: surgical procedures, minimally invasive research abstracts see: surgical procedures, operative: surgical procedures, minimally invasive research

PUBMED ID PMID:

MEDLINE DATE:

Renal cell carcinoma. Journal Published:

PUBLICATION TYPE: Review

Journal: Current opinion in oncology

VOLUME: 18

Page Numbers: 289-96

Journal Abbreviation:

ISSN: 1531-703X

DAY: 20

MONTH: May

YEAR: 2006

Renal cell carcinoma. Information

Number of References: 89

LANGUAGE: eng

NlmUniqueID: 9007265

Renal cell carcinoma. Keywords Mesh Terms:

KEYWORDS: Surgical Procedures, Minimally Invasive

MESH TERMS: adverse effects

Chemical & Substance for Abstract: Renal cell carcinoma. Information

Substance Name: Angiogenesis Inhibitors

Registry Number: 0

Grant and Affiliation Information for Renal cell carcinoma.

AFFILIATION: Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Opin Oncol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Renal cell carcinoma Related Publications

• A 50-year-old man with chronic low back pain.
• Chapter twenty-two mechanisms and methods in glucose metabolism and cell death.
• Cytologic study of pleural effusions.
• Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways.
• Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.
• Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.
• IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival.
• Lesions of the heart.
• Mitochondria, cell death, and B cell tolerance.
• New roles for pyruvate kinase M2: working out the Warburg effect.
• Pathologic conditions affecting brain and spinal cord. I.
• Pathologic conditions affecting brain and spinal cord. II.
• Pharmacotherapy for acute pain: implications for practice.
• Preoperative tyrosine kinase inhibition as an adjunct to debulking nephrectomy.
• Renal cell carcinoma.
• Reply to drs. Joshi, kehlet, and rawal.
• The promise of an effective treatment for sacroiliac-related low back pain.
• Variable osteology of the sixth cervical vertebra in relation to stellate ganglion block.